Tag:
Philogen
Latest Headlines
Latest Headlines
Philogen cancels IPO after Bayer pulls out of cancer deal
Philogen's bid to become the first European biotech to IPO in 2011 has hit a snag. The biotech had planned to sell a 23 percent stake and debut on the Milan stock exchange this Friday. The company,
Philogen prepares the first European biotech IPO in '11
After watching a string of shaky biotech IPOs debut in the U.S., Philogen is making a bid to become the first European drug developer to go public this year. And some analysts have been making
